Skip to content

Dr. Geubels Charlotte

Active Private limited companyfounded 2023active for 3 yearsWijnegemsteenweg 39E, 2970 SchildeKBO/BCE: BE 0802.821.389

Lifetime

3 annual accounts with figures on one time axis
peak of €61,730 in 2025
€61,730▲ 192%
peak of €47,395 in 2025
€47,395▲ 194%
peak of €67,145 in 2025
€67,145▲ 240%
€15,265▲ 122%
Board1 name since 2023
1 director
Documentsfilings and deeds
06-03-2026147 days before the deadline
2025micro format
Gross margin from €21,116 to €61,730Result from €16,125 to €47,395Wijnegemsteenweg 77 Bus F 2970 'S Gravenwezel 09-10Registered office moved from Schilde to s' Gravenwezel 28-04Equity from €19,751 to €67,145Debts from €6,882 to €15,265

Key points

from the 2025 annual accounts

Turnover

≈ €140,000 estimated

The micro format states no turnover.

Investments

€3,500 2.1 times depreciation
20242025

Green is investment, beige is depreciation. Machinery stands 42.2% higher than in 2024.

Liquidity

4.99 was 3.23 in 2024

Short-term debts rose from €6,882 to €15,265.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,330 companies had the same profile as Dr. Geubels Charlotte has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,330 companies, not a prediction for Dr. Geubels Charlotte. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 16-06-2023
  • 100 sharesdeed of 20-06-2023
Board & ownership

Recent changes

Wijnegemsteenweg 77 Bus F 2970 'S Gravenwezel is in office as director · General meeting of 19-06-2025 · Gazette deed
Registered office moved from Schilde to s' Gravenwezel The registered office moved from Boerendreef 18, 2970 Schilde to Wijnegemsteenweg 77 Bus F, 2970 s' Gravenwezel · General meeting of 12-03-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0802821389
First establishment Wijnegemsteenweg 39, Schilde
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Geubels Charlotte Schilde €82,410 €61,730 81.5% -
Dokter Verellen Camille Brasschaat €94,877 €60,491 83.6% -
SRKmed Brussels €80,905 €57,694 81.6% -
Cabinet Médical WIBALD Stavelot €93,413 €59,163 15.4% 0.9
NOLET MEDCO Watermael-Boitsfort €75,704 €65,631 90.6% -
VDB.M Saint-Ghislain €95,606 €60,621 62.2% -
SB Management Liège €77,152 €57,666 45.4% -

These companies have the same main activity as Dr. Geubels Charlotte: general medical practice (NACE 86210). They are comparable in size and age: total assets between €75,700 and €95,600, founded in 2023.

Official details

Source: KBO
Status
Active since 16-06-2023Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.346.226.2012970 Schilde, since 01-10-2023
Financial year end
31 December
Peppol
Reachable since 09-10-2024
Company details

Annual accounts 2025

€82,410▲ 209%
Filing
Filed on 06-03-2026, 147 days before the end of the filing period
Financials

Insights on Dr. Geubels Charlotte

Dr. Geubels Charlotte files the micro format. That format states no turnover. The gross margin rose from €4,711 in 2023 to €61,730 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Geubels Charlotte

What is the company number of Dr. Geubels Charlotte?
The company number of Dr. Geubels Charlotte is 0802.821.389. The VAT number is the same number with BE in front: BE 0802.821.389.
Where is Dr. Geubels Charlotte based?
The registered office is at Wijnegemsteenweg 39E, 2970 Schilde.Company details
What does Dr. Geubels Charlotte do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Geubels Charlotte?
Dr. Geubels Charlotte is a private limited company (BV).
When was Dr. Geubels Charlotte founded?
Dr. Geubels Charlotte was founded on 16-06-2023.
Is Dr. Geubels Charlotte still active?
Yes, Dr. Geubels Charlotte is an active enterprise in the KBO register.
What is the turnover of Dr. Geubels Charlotte?
The turnover in financial year 2025 is about €140,000. This figure is estimated from the gross margin of €61,730 and 33 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.Financials
Is Dr. Geubels Charlotte profitable?
In financial year 2025, Dr. Geubels Charlotte made a profit of €47,395.
Where can I find the annual accounts of Dr. Geubels Charlotte?
Dr. Geubels Charlotte filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Geubels Charlotte due?
Dr. Geubels Charlotte must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.